Entry date | September 24, 2002 12:00 +1GMT
| Last update | July 24, 2019 19:24 +1GMT
|
Allergome Code | 386
|
Name | Hev b 2 
|
Common Names | Glucanase, k216
|
Biological Function | 1,3-Glucanases, Glucanases
|
Isoforms, Variants, Epitopes | Hev b 2.0101
|
Links to Molecule Sequences | Hev b 2 - A0A074 - UNIPROT, Hev b 2 - A2TJX4 - UNIPROT, Hev b 2 - A2TM12 - UNIPROT, Hev b 2 - A2TM13 - UNIPROT, Hev b 2 - A2TM14 - UNIPROT, Hev b 2 - D1M8S7 - UNIPROT, Hev b 2 - D2K935 - UNIPROT, Hev b 2 - G9G7S0 - UNIPROT, Hev b 2 - I2EC77 - UNIPROT, Hev b 2 - I2EC78 - UNIPROT, Hev b 2 - Q0ZAE6 - UNIPROT, Hev b 2 - Q7XJ83 - UNIPROT, Hev b 2 - Q9FUC6 - UNIPROT, Hev b 2 - Q9ZP99 - UNIPROT, Hev b 2.0101 - P52407 - UNIPROT
|
Sources | |
Links to Source Taxonomy | Hev b - 3981 - NCBI, Hev b - 3981 - UniProt, Hev b - 506431 - ITIS, Hev b - Discover Life, Hev b - Wikipedia
|
Links to Source Images | Hevea brasiliensis on Google images | Tissues | Latex
|
Routes of Exposure | Contact_Skin, Inhalation
|
Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | France | IgE | 97 | 69.000 | 20120706, Garnier L
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 101 | 60.400 | 20101118, Bublin M
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 48 | 33.330 | 20101118, Bublin M
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2007 | Finland | IgE | 79 | 15.000 | 20070910, Palasuo T
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2007 | Spain | IgE | 74 | 5.000 | 20070910, Palasuo T
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2007 | United States | IgE | 62 | 11.000 | 20070910, Palasuo T
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 23 | 0.000 | 20060324, Sanz ML
| 3.1.2 - Source Sensitized - High Exposure (SPT) | 2003 | United States | SPT | 62 | 63.000 | | 5.1.1 - Source Exposed (Symptoms) | 2000 | United States | IgE | 44 | 61.400 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2000 | Canada | SPT | 29 | 6.900 | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | United States | IgE | 28 | 32.000 | 2000, Yeang HY
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Finland | IgE | 8 | 13.000 | 2000, Yeang HY
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1998 | Japan | IgE (IB) | 15 | 40.000 | |
| References | Biochemistry / Structure / Function 2014: 20140331, Lollier V
- 20140217, Rodriguez-Romero A
2013: 20131118, Berthelot K
- 20130731, DallAntonia F
- 20130204, Rahman AY
2012: 20121214, Power TD
- 20120221, Mishra A
2011: 20110131, Sontimuang C
2010: 20101206, Sontimuang C
- 20100708, Wang X
- 20100315, DAmato A
- 20100208, Rouvinen J
2009: 20090129, Barre A
2007: 20070910, Palasuo T
- 20070904, Fuentes-Silva D
2006: 20061215, Futamura N
- 20060620, Thanseem I
2002: 2002a, Yagami T
2001: 20010912, Subroto T
1998: 1998, Yagami T
... complete Reference listing ->
Molecular Biology 2006: 20060620, Thanseem I
1995: 1995, Chye ML
Immunochemistry / Allergenicity 2014: 20140217, Rodriguez-Romero A
2012: 20121029, Gaspar A
2010: 20100315, DAmato A
2009: 20090129, Barre A
2007: 20070919, Raulf-Heimsoth M
- 20070910, Palasuo T
- 20070309, Wagner S
2005: 20050323, Palomares O
2004: 20041120, Wagner S
- 20040914, Yeang HY
- 20040327, Arif SA
2002: 2002a, Yagami T
- 2002, Chardin H
1998: 1998, Yagami T
1997: 1997a, Posch A
1995: 1995, Alenius H
Immune-mechanisms / Genetics 1999: 1999, Johnson BD
Detection - Source Extracts, Food Products, Drug Preparations 2011: 20110505, Li HL
- 20110131, Sontimuang C
2010: 20101206, Sontimuang C
2008: 20080208, Medeiros S
2007: 20070309, Wagner S
2006: 20060704, Yeang HY
- 20060620, Thanseem I
2004: 20040914, Yeang HY
2003: 2003, Sastre J
2000: 2000, Yeang HY
1996: 19969211, Subroto T
Detection - Allergy Diagnostic and Immunotherapeutic Products 2012: 20120402, Lasa Luaces EM
Detection - Source Tissues 2006: 20060620, Thanseem I
1996: 19969211, Subroto T
1995: 1995, Chye ML
Epidemiology 2007: 20070919, Raulf-Heimsoth M
- 20070910, Palasuo T
- 20070706, Smith AM
2003: 2003, Bernstein DI
2000: 2000, Yip L
- 2000, Yeang HY
- 2000, Kurup VP
Diagnosis 2012: 20121029, Gaspar A
- 20120706, Garnier L
- 20120402, Lasa Luaces EM
2011: 20111011, Kespohl S
2010: 20101118, Bublin M
2009: 20091130, Rouge P
- 20090211, Yagami A
- 20090129, Barre A
2008: 20080403, Antonicelli L
- 20080208, Medeiros S
- 20080131, Yeang HY
- 20080131, Palosuo T
2007: 20070706, Smith AM
- 20070514, Lopata AL
- 20070126, Mari A
2006: 20061102, Mahler V
- 20060831, Jappe U
- 20060704, Yeang HY
- 20060324, Sanz ML
- 20060228, Rozynek P
... complete Reference listing ->
Review, Editorial, Report Citations, Other Resources 2014: 20141202, Berthelot K
- 20141105, Siracusa A
- 20141015, Turnbull JL
- 20140428, Ho MH
- 20140403, Sinha M
2013: 20130807, Niederberger V
- 20130430, de Sa AB
- 20130306, Gaspar A
2012: 20121015, Cabanes N
- 20120730, Nettis E
- 20120618, San Miguel Hernandez A
- 20120314, Sell AM
- 20120229, Raulf-Heimsoth M
- 20120111, Treudler R
2011: 20110701, Palosuo T
- 20110509, Garcia BE
- 20110414, Sanz ML
- 20110212, Barre A
2010: 20101027, Niggermann B
- 20100614, Bueno de Sa A
... complete Reference listing -> |
|